Home Ingredients Chaga Mushroom (Inonotus obliquus)
Immune SupportAntioxidantLongevity

Chaga Mushroom (Inonotus obliquus)

Inonotus obliquus
Evidence Level
Limited
3 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Chaga is a parasitic fungus that grows on birch trees in cold climates — used in Russian, Korean, and Eastern European traditional medicine for centuries. Distinguished by high concentration OF melanin, betulinic acid (from birch bark), and beta-glucan polysaccharides. Studied for antioxidant effects, immune support, anti-inflammatory, and anti-cancer research. Critical caution: very high oxalate content can cause kidney damage in susceptible individuals.

Studied Dose 500-2,000 mg/day extract; standardized to beta-glucan content (typically 30%+); traditional tea 3-4 g dried per cup
Active Compound Beta-glucans, betulinic acid, melanin, polyphenols, triterpenes (inotodiol, lanosterol)

Benefits

Antioxidant Activity

Chaga has one of the highest ORAC (oxygen radical absorbance capacity) values among foods/supplements — exceptional in vitro antioxidant capacity. Active compounds include polyphenols, melanin, and various phenolic compounds. In vitro antioxidant activity dramatic; clinical translation more modest.

Supported by Trial 1, Trial 3

Immune Modulation

Beta-glucans activate innate immune cells (macrophages, NK cells, dendritic cells) — similar mechanism to other medicinal mushrooms. Modest immune support evidence.

Supported by Trial 2

Anti-Inflammatory Effects

Reduces inflammatory cytokines and oxidative stress markers in animal models. Modest human evidence.

Supported by Trial 1, Trial 2

Anti-Cancer Research

Extensive in vitro evidence for cancer cell apoptosis induction — particularly betulinic acid (concentrated in chaga from birch). Animal models supportive. Human clinical translation limited; not established cancer therapy.

Supported by Trial 3

Blood Sugar Modest Effects

Animal models show modest blood sugar improvements. Limited human clinical evidence.

Supported by Trial 3, Trial 1

Mechanism of action

1

Beta-Glucan Immune Activation

Beta-1,3 and beta-1,6 glucans bind to dectin-1 receptors on immune cells, activating innate immune responses. Same mechanism as other medicinal mushroom beta-glucans.

2

Betulinic Acid (From Birch)

Betulinic acid is concentrated in chaga because the fungus parasitizes birch trees and accumulates birch bark compounds. Has antiviral, anti-inflammatory, and apoptosis-inducing effects in vitro.

3

Melanin Antioxidant

Chaga's distinctive black appearance comes from high melanin content — natural pigment with antioxidant properties. Contributes to ORAC value.

4

Triterpene Bioactivity

Inotodiol, lanosterol, and other triterpenes have anti-inflammatory and modulatory effects on multiple cellular pathways.

Clinical trials

1
Antioxidant Activity (Preclinical)
PubMed

In vitro and cell-based studies of Inonotus obliquus extract, including Cui et al. (J Ethnopharmacol, 2005).

Cell cultures and isolated tissues. No human trials.

Chaga extract shows strong antioxidant activity in the laboratory, scavenging free radicals and protecting cells from oxidative damage. These results come from test-tube and cell models. No human clinical trials have tested chaga for antioxidant outcomes.

2
Immune Activation (Preclinical, Mechanistic)
PubMed

Mechanistic study of Inonotus obliquus polysaccharides on immune cells (Wold et al., Commun Biol, 2024).

Immune cell cultures. No human trials.

Chaga beta-glucans and polysaccharides act on Toll-like receptors and can activate macrophages in laboratory models, the proposed basis for its immune-modulating reputation. This is cell-based mechanistic evidence, not a human trial.

3
Anti-Cancer Research (Preclinical, Not a Treatment)

In vitro and animal studies of chaga extracts and the triterpene betulinic acid, summarized in mechanistic reviews.

Cancer cell lines and animal models. No human trials.

Chaga compounds such as betulinic acid trigger apoptosis in cancer cell lines and slow tumor growth in animals. Critically, there are no human clinical trials, chaga is not a cancer treatment, and marketing claims far exceed the evidence.

Side effects and drug interactions

Common Potential side effects

Oxalate nephropathy / kidney stones — chaga has very high oxalate content; case reports of acute kidney injury with regular chaga consumption in susceptible individuals (especially those with kidney disease or oxalate-prone history); Japanese 2014 case report documented end-stage renal disease attributed to chronic chaga use.
Bleeding risk — modest antiplatelet effects.
GI distress at high doses.
Hypoglycemia in sensitive individuals.
Allergic reactions rare.
Mold/mycotoxin contamination possible in poorly-sourced products.

Important Drug interactions

Anticoagulants (warfarin, DOACs) — additive bleeding risk; case report of warfarin INR elevation with chaga; avoid without medical supervision.
Antiplatelet drugs — additive bleeding risk.
Insulin / diabetes medications — modest hypoglycemic effect; monitor.
Immunosuppressants — chaga's immune activation could theoretically interfere; consult.
Pre-surgery — discontinue 2 weeks before.

More Immune Support Ingredients

Immune Support
Vitamin C
Vitamin C (L-ascorbic acid) is a water-soluble essential nutrient that humans cannot synth…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…
Immune Support
Vitamin A
Vitamin A is a fat-soluble nutrient essential for vision, immune defense, reproduction, an…
Immune Support
EpiCor® (Postbiotic Yeast Fermentate — Cargill)
EpiCor® is a postbiotic ingredient from Cargill — derived from the fermentation of Sacchar…

Explore Other Ingredients

Metabolic Health
Berberine
Berberine is a bioactive compound extracted from plants like barberry and goldenseal, know…
Metabolic Health
Fenugreek
Fenugreek is an aromatic seed used both as a culinary spice and a supplement, best known f…
Antioxidant
Moringa
Moringa (Moringa oleifera) is a fast-growing tree whose leaves are dried into a nutrient-d…

Frequently asked questions about Chaga Mushroom (Inonotus obliquus)

How much chaga should I take?

Common doses are around 1 to 3 grams per day of chaga extract or powder, often as a tea or capsule. Look for hot-water or dual extracts standardized to beta-glucans, since the beneficial compounds need extraction.

What is chaga used for?

Chaga is a mushroom that grows on birch trees, valued for its high antioxidant content and traditionally used for immune support and general wellness. Human research is still limited, so claims should be viewed cautiously.

Does chaga contain oxalates?

Yes, chaga is high in oxalates, and very heavy use has been linked in rare reports to kidney problems. People with a history of kidney stones or kidney disease should be cautious and keep intake moderate.

Is chaga safe?

For most people, moderate use is generally well tolerated. Because of its oxalate content and possible effects on blood sugar and blood clotting, those with kidney issues, on blood thinners, or with diabetes should check with a doctor.

What is Chaga Mushroom?

Chaga is a parasitic fungus that grows on birch trees in cold climates — used in Russian, Korean, and Eastern European traditional medicine for centuries. Distinguished by high concentration OF melanin, betulinic acid (from birch bark), and beta-glucan polysaccharides.

What is Chaga Mushroom used for?

Chaga Mushroom is researched primarily for Immune Support, Antioxidant, and Longevity. Chaga has one of the highest ORAC (oxygen radical absorbance capacity) values among foods/supplements — exceptional in vitro antioxidant capacity. Active compounds include polyphenols, melanin, and various phenolic compounds.

What is the recommended dosage of Chaga Mushroom?

The clinically studied dose is 500-2,000 mg/day extract; standardized to beta-glucan content (typically 30%+); traditional tea 3-4 g dried per cup Always follow the product label and check with a healthcare provider for personal advice.

Is Chaga Mushroom safe, and does it have side effects?

For most healthy adults, Chaga Mushroom is well tolerated at studied doses. Reported effects can include: Oxalate nephropathy / kidney stones — chaga has very high oxalate content; case reports of acute kidney injury with regular chaga consumption in susceptible individuals (especially those with kidney disease or oxalate-prone history); Japanese 2014 case report documented end-stage… It may also interact with some medications. Chaga Mushroom is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Chaga Mushroom interact with any medications?

Possible interactions include: Anticoagulants (warfarin, DOACs) — additive bleeding risk; case report of warfarin INR elevation with chaga; avoid without medical supervision. Antiplatelet drugs — additive bleeding risk. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Chaga Mushroom?

NutraSmarts rates the evidence for Chaga Mushroom as Limited (2 out of 5). It is backed by 3 clinical trials and 6 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(6 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Cui Y, Kim DS, Park KC. Antioxidant effect of Inonotus obliquus. J Ethnopharmacol. 2005;96(1-2):79-85. doi: 10.1016/j.jep.2004.08.037.PubMedUsed to support: In vitro evidence for the antioxidant activity of chaga (Inonotus obliquus) extract. Laboratory study, not a human trial.
  2. Wold CW, Christopoulos PF, Arias MA, Dzovor DE, et al. Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity. Commun Biol. 2024;7(1):222. doi: 10.1038/s42003-024-05853-y.PubMedUsed to support: Cell-based mechanistic evidence that chaga polysaccharides activate Toll-like receptors and macrophages, the proposed basis for immune modulation. Not a human trial.
  3. Delgersaikhan N, Odkhuu E, Khaltar P, Samdan E, et al. Antidiabetic activity of Inonotus obliquus water extract in alloxan-induced diabetic mice. J Complement Integr Med. 2024;21(4):472-480. doi: 10.1515/jcim-2024-0316.PubMedUsed to support: Animal study (diabetic mice) in which chaga water extract modestly lowered blood glucose. Supports the modest blood-sugar benefit at a preclinical level only; no human evidence.
  4. Gao Y, Wang D, Zheng Y, Sun H. Betulinic acid and apoptosis-involved pathways: Unveiling its bidirectional regulatory role. Eur J Pharmacol. 2025;1008:178361. doi: 10.1016/j.ejphar.2025.178361.PubMedUsed to support: Review of how betulinic acid, a triterpene found in chaga, regulates apoptosis pathways in cancer cells. Mechanistic and preclinical; chaga is not a proven cancer therapy.
  5. Ern PTY, Quan TY, Yee FS, Yin ACY. Therapeutic properties of Inonotus obliquus (Chaga mushroom): A review. Mycology. 2024;15(2):144-161. doi: 10.1080/21501203.2023.2260408.PubMedUsed to support: Review summarizing chaga's reported antioxidant, immune, anti-inflammatory, and antidiabetic properties, noting that most evidence is preclinical and human data are limited.
  6. Wang Y, Gu J, Wu J, Xu Y, et al. Natural Products and Health Care Functions of Inonotus obliquus. Curr Issues Mol Biol. 2025;47(4):269. doi: 10.3390/cimb47040269.PubMedUsed to support: Recent review of chaga's bioactive compounds (polysaccharides, triterpenes, polyphenols) and their proposed health functions, drawn largely from laboratory and animal research.